Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1983-09-26
1987-08-25
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 21, 514822, A61K 31725, C08B 3710
Patent
active
046893237
ABSTRACT:
There is disclosed a process for producing a convalently bound heparin--antithrombin-III complex useful for anticoagulant therapy, a covalently bound heparin--antithrombin-III complex produced by the process, a composition thereof in a pharmaceutically acceptable carrier, and a method for preventing and treating thromboembolisms by administering to a human patient a therapeutically effective amount of the complex or preparation.
REFERENCES:
patent: 4301153 (1981-11-01), Rosenberg
patent: 4446126 (1984-05-01), Jordan
Bjork et al., Permanent Activation of Antithrombin by Covalent Attachment of Heparin Oligosaccharides, FEBS Letters, 143(1), pp. 96-100 (1982).
Ceustermans et al., Preparation, Characterization, and Turnover Properties of Heparin--Antithrombin III Complexes Stabilized by Covalent Bonds, J. Biol. Chem. 257(7), pp. 3401-3408 (1982).
Hoylaerts et al., Covalent Complexes Between Low Molecular Weight Heparin Fragments and Antithrombin III-Inhibition Kinetics and Turnover Parameters, Chem. Abs. 98:213439k (1983).
Miura et al., Anticoagulant Activity of Artificial Biomedical Materials with Co-Immobilized Antithrombin III and Heparin, Biochimie 62, pp. 595-601 (1980).
Jordan et al., Fractionation of Low Molecular Weight Heparin Species and Their Interaction with Antithrombin, J. Biol. Chem. 254(8), pp. 2902-2913 (1979).
Tam et al, Proc. Natl. Acad. Sci., 73 (6), 2128 (1976).
Marshall et al, J. Biol. Chem., 254(4), 1081 (1976).
Kohn et al, Enzyme Microb. Technology, 4, 161 (1982), and Biochem. Biophys. Res. Commun., 107 (3), 878 (1982).
Rao et al, Thromb. Res., 24, 181 (1981).
Bonen et al, Thromb. Res., 27, 123 (1982).
Baird et al, J. Bone Jt. Surg., 59A, 1061 (1977).
Rosenberg et al, Proc. Natl. Acad. Sci., 75 (7), 3065 (1978).
Rosenberg et al, Biochem. Biophys. Res. Commun., 86 (4), 1319 (1979).
Lam et al, Biochem. Biophys. Res. Commun., 69 (2), 570 (1976).
Hook et al, FEBS Letters 66 (1), 90 (1976).
Jordan Robert E.
Mitra Gautam
Brown Johnnie R.
Miles Laboratories Inc.
Rollins Jr. John W.
Simonton Pamela A.
LandOfFree
Covalently bound heparin--antithrombin-III complex does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Covalently bound heparin--antithrombin-III complex, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Covalently bound heparin--antithrombin-III complex will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1923089